Trial Profile
An Open-label, Single-center, Drug-drug Interaction Study to Assess the Effect of SK-0403 on the Pharmacokinetics, Pharmacodynamics and Safety of Multiple Oral Administration of Miglitol in Japanese Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Dec 2016
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary) ; Miglitol
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Kowa; Sanwa Kagaku Kenkyusho
- 25 May 2016 New trial record